Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02500238
Other study ID # IRB201500475
Secondary ID OCR14742
Status Completed
Phase
First received
Last updated
Start date November 2015
Est. completion date November 2016

Study information

Verified date December 2018
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Electronic cigarette use may be less harmful than cigarettes in adults, however, limited data exists examining passive electronic cigarette exposure and child health outcomes. The current study seeks to compare health-related outcomes among youth who reside with non-smokers, cigarette smokers, and electronic cigarette users. The investigators propose to conduct a small pilot study with 30 youth, ages 6-17 and a caregiver. Three groups of 10 parent-child dyads will be recruited: 1) control group: parents who are non-smokers/non-vapers, 2) smoking group: parents who are exclusive cigarette smokers, and 3) vaping group: parents who are exclusively ECIG users. Groups will be compared across the following variables: child lung function and biomarkers of nicotine.


Description:

The current study seeks to compare health-related outcomes among youth who reside with non-smokers, cigarette smokers, and electronic cigarette users.

Control Group: will consist of participants ages 6 - 17 who live in a home with adults who do not smoke. A brief breathing test will verify a non-smoker and/or are not around a certain amount of smoke in the environment (live with a smoker). The participant will be asked to complete a series of brief questionnaires that asks about basic demographic information, medical history, and that asks about their smoking history. The participant's will also be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.

Vaping Group: will consist of participants ages 6 -17 who live in a home with adults who currently use electronic cigarettes. A brief breathing test will verify a non-tobacco smoker and/or are not around a certain amount of smoke in the environment (live with a tobacco smoker). The participant will be asked to complete a series of brief questionnaires that asks about basic demographic information, smoking or vaping history and patterns of use, and medical history. The participant will be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.

Smoking Group: will consist of participants ages 6 - 17 who live in a home with adults who currently smoke cigarettes. Participants will then be asked to complete a series of brief questionnaires that asks about basic demographic information, smoking or vaping history and patterns of use, and medical history. The participant will also be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria:

For the control group the caregiver must self-report:

1. never smoking or not smoking for at least the past 12 months;

2. that no one living in the home is a current smoker or has smoked in the home for the past 6 months; and

3. have a breath carbon monoxide reading of = 6ppm.

For the smoking group caregivers must:

1. smoke at least 10 cigarettes per day for the past year;

2. indicate that they smoke in the car or home = 3 times per week; and

3. do not use non-cigarette tobacco (e.g., cigars, chewing tobacco).

For the vaping group caregivers must:

1. exclusively use EC for the past 3 months (no cigarette or other tobacco use); and

2. no one living in the home is a current tobacco smoker or has smoked in the home for the past 6 months; and

3. have a breath carbon monoxide reading of = 6ppm.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Saliva sample
All participants will provide a saliva sample.
Urine Sample
All participants will provide a urine sample.
Toe nail clippings
All participants will provide toe nail clippings.
Breath carbon monoxide test
All participants will provide breath carbon monoxide tests

Locations

Country Name City State
United States Uf Ctsi Crc Gainesville Florida
United States OUHSC Oklahoma City Oklahoma

Sponsors (2)

Lead Sponsor Collaborator
University of Florida University of Oklahoma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of lung function Child lung function will be measured at the study visit. Forced expiratory volume in the first second will be assessed. Day 1
Secondary Assessment of cotinine in saliva Child saliva samples will be collected at the study visit. Samples will be assessed for cotinine levels. Day 1
Secondary Assessment of cotinine in urine Child urine samples will be collected at the study visit. Samples will be assessed for cotinine levels. Day 1
Secondary Assessment of nicotine in toenail clippings Child toenail samples will collected at the study visit. Samples will be assessed for nicotine levels. Day 1
Secondary Assessment of cotinine in toenail clippings Child toenail samples will be collected at the study visit. Samples will be assessed for cotinine levels. Day 1
Secondary Assessment of tobacco specific nitrosamine in toenail clippings Child toenail samples will be collected at the study visit. Samples will be assessed for NNAL levels. Day 1
Secondary Assessment of tobacco specific nitrosamine in urine Child urine samples will be collected at the study visit. Samples will be assessed for NNAL levels. Day 1
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT03448900 - Intervention Study for Smoking Cessation in Spanish College Students N/A